BioRender: Pricing, Limitations, and the Best Alternatives in 2026

BioRender built itself into the default tool for scientific illustration by doing one thing brilliantly: making it easy for non-designers to produce professional-looking figures. For a field where most researchers have never opened Adobe Illustrator, that was transformative. Today, millions of scientists use it to build pathway diagrams, experimental schematics, and publication figures.

But "dominant" doesn't mean "without problems." Over the past two years, BioRender has become the center of significant controversy around copyright, open-access licensing, and cost—controversies serious enough that researcher Will Ratcliff publicly asked on X: "Time to ditch BioRender?" In 2026, that question is more relevant than ever.

This article breaks down what BioRender actually costs, what its real limitations are, and which alternatives are worth your attention—including tools built specifically for clinical and medical illustration.

BioRender Pricing: What You'll Actually Pay

BioRender offers a free tier, but its restrictions make it effectively unusable for most research purposes. Here's the full pricing breakdown:

Free Plan: You can create figures at no cost, but you cannot use them in publications, commercial materials, or for any profit-generating purpose. For most researchers, this limits the free plan to sketching and internal presentations only.

Academic Individual — $35/month: Designed for researchers at universities, research institutes, NGOs, and government non-profits. This plan unlocks publication rights and premium icons, and it's what most academic researchers working independently will use.

Undergraduate — $20 per 4-month cycle: A discounted plan for students paying out of pocket. BioRender bills this in semester-length cycles rather than monthly.

Academic Lab — $99/month: Covers a PI plus four lab members, with shared folders, commenting, and admin controls. For active labs producing figures regularly, this often works out to a better per-user rate.

Industry Individual — approximately $79–$115/month: The range reflects pricing variations that have appeared across BioRender's own help pages and third-party sources. Professionals at for-profit companies who use BioRender figures for commercial purposes fall into this tier.

Industry Team — $395/month: For larger commercial organizations needing multi-user access.

Enterprise: Custom pricing, negotiated directly with BioRender.

Some universities have negotiated institutional licenses that bring per-user costs down significantly—Michigan State University subsidizes access at $100 per user per year, and Boston University covered it institutionally in 2026. If your institution has a deal, that's the best way to use BioRender affordably.

Is BioRender Free? The Honest Answer

Technically yes—but practically no. The free plan won't let you publish your figures in journals, use them in grant submissions, or include them in any commercial materials. Given that publication is the primary output of most scientific work, the free plan is more of a trial than a functional tool. You'll need a paid subscription the moment you want to use a figure for anything that matters professionally.

This reality catches many new users off guard, particularly students who assume "free to create" means "free to publish."

BioRender's Copyright Problem: What Researchers Need to Know

The most significant limitation of BioRender isn't the price—it's the licensing structure, which generated substantial backlash in 2024 and remains a source of tension in 2026.

The issue crystallized when researcher Simon Dürr discovered that over 9,000 published studies contained BioRender figures published under Creative Commons CC-BY open-access licenses—but BioRender's terms appeared to conflict with the open-reuse requirements that CC-BY licenses mandate. CC-BY requires that anyone can freely reuse and modify the work without additional restrictions. BioRender's terms, by contrast, require a paid account to modify figures, which critics argued constitutes exactly the kind of additional restriction that CC-BY prohibits.

Chemistry World covered the story; Plagiarism Today analyzed the legal dimensions. BioRender updated its terms in September 2024, introducing an explicit open-access publication license that users must generate for each figure published in an open-access journal, along with a required citation. Critics argued the update still didn't resolve the fundamental tension with CC-BY's terms.

What this means practically: if you publish in open-access journals, you need to carefully read BioRender's current licensing terms, generate the correct license for each figure, and include the required citation. Skipping this step puts your published work in legal uncertainty.

How to Cite BioRender Figures

If you do use BioRender for publication, citation is mandatory. Here's how it works:

For original figures you create, the required credit is "Created with BioRender.com," included in the figure caption, references, or acknowledgments depending on journal guidelines.

For figures adapted from BioRender templates, the citation format is: "Adapted from '[Template Name]', by BioRender.com ([Year]). Retrieved from [URL]."

For open-access publications, you must generate a unique publication license URL through BioRender's export workflow. BioRender generates this automatically when you export with a publication license selected, and the unique URL must be included in your citation.

Importantly, you typically don't need the publication license at the submission stage—journals usually request it after acceptance. But it's worth generating it early to avoid scrambling post-acceptance.

Other Meaningful Limitations

Beyond licensing, researchers frequently cite several other constraints:

No offline access. BioRender is entirely web-based, with no offline functionality. For researchers in environments with unreliable internet—field sites, travel, or network outages—this is a genuine constraint.

Narrow disciplinary focus. BioRender's icon library is deep in molecular biology and cell biology but thinner in other scientific areas. Clinical medicine, surgery, anatomy, and the physical sciences have noticeably less coverage. Researchers in these fields often find themselves searching for icons that simply don't exist in the library.

The "BioRender look." With millions of users drawing from the same icon library, BioRender figures have developed a recognizable aesthetic. Some reviewers and editors have begun noting when figures look like templated BioRender outputs—which can undercut the impression of original scientific illustration.

Authorship and licensing friction. BioRender requires that the first author of a paper hold the license, regardless of who actually created the figure. If a graduate student builds a figure but doesn't have a subscription, the PI or first author must hold the license and export it. This creates administrative friction in collaborative lab environments.

The Best BioRender Alternatives in 2026

Mind the Graph

Mind the Graph is the most direct BioRender competitor, with a library of over 75,000 scientific illustrations across 80+ fields. It exports at up to 1200 DPI (compared to BioRender's 600 DPI), and its pricing starts at $7/month. For researchers who want similar drag-and-drop functionality with more flexible licensing and higher-resolution outputs, Mind the Graph is the most obvious switch.

Natomy AI

For medical professionals working with clinical images—physicians documenting procedures, surgeons creating educational materials, researchers illustrating anatomical concepts—Natomy AI takes a different approach entirely. Rather than giving you a library of pre-made icons to assemble, Natomy AI transforms actual clinical photographs into professional anatomical illustrations using AI. Upload a clinical photo and receive a publication-quality illustration that reflects your specific case, patient anatomy, or procedure. This matters in clinical medicine, where generic icons often don't capture the specificity that professional medical illustration requires.

Free and Open-Source Options

Several solid free options exist for researchers with more time than budget: NIH BioART offers free, public-domain scientific icons from the National Institutes of Health. Bioicons and Scidraw are community-built repositories of freely licensed scientific illustrations. Smart Servier Medical Art provides over 3,000 medical and biological images under Creative Commons Attribution licensing, which resolves the open-access conflict entirely.

For researchers comfortable with vector graphics, Inkscape is a powerful open-source editor that, combined with these free icon repositories, can produce publication-quality figures without subscription costs.

Illustrae

Illustrae uses AI to generate scientific figures from text descriptions, sketches, or photos—similar in concept to Natomy AI but oriented toward general scientific diagrams rather than medical illustration specifically. For researchers who need custom diagrams that don't fit pre-built icon libraries, AI-generation tools like Illustrae represent a different approach worth exploring.

Should You Switch?

BioRender remains the most polished and widely recognized tool for molecular and cellular biology figures. If your institution has an institutional license and you publish primarily in subscription journals rather than open-access venues, the practical friction is low. The tool works, the outputs are professional, and reviewers recognize the format.

If you're in clinical medicine or anatomy, however, BioRender's icon library is likely to leave you frustrated—and this is where tools like Natomy AI become genuinely useful. Transforming your own clinical images into polished illustrations solves the specificity problem that generic icon libraries can't address.

If open-access publishing is central to your work, pay careful attention to BioRender's current licensing terms before building a workflow around it. The September 2024 update addressed some concerns, but the legal debate hasn't fully resolved, and the administrative overhead of managing per-figure open-access licenses adds friction.

The broader lesson from BioRender's 2024 controversy is that tools that control licensing on content you create carry risks that aren't always obvious until they become problems. For long-term research workflows, licensing clarity matters as much as design capability.

---

Need professional medical illustrations from your clinical photos? Try Natomy AI at natomy.com — built specifically for physicians, surgeons, and medical researchers who need publication-quality anatomical illustrations without the constraints of generic icon libraries.